108 related articles for article (PubMed ID: 27670395)
1. Impact of serum and dialysates obtained from chronic hemodialysis patients maintained on high cut-off membranes on inflammation profile in human THP-1 monocytes.
Trojanowicz B; Ulrich C; Fiedler R; Storr M; Boehler T; Martus P; Pawlak M; Glomb MA; Henning C; Templin M; Werner K; Zickler D; Willy K; Schindler R; Girndt M
Hemodial Int; 2017 Jul; 21(3):348-358. PubMed ID: 27670395
[TBL] [Abstract][Full Text] [Related]
2. Modulation of leucocytic angiotensin-converting enzymes expression in patients maintained on high-permeable haemodialysis.
Trojanowicz B; Ulrich C; Fiedler R; Martus P; Storr M; Boehler T; Werner K; Hulko M; Zickler D; Willy K; Schindler R; Girndt M
Nephrol Dial Transplant; 2018 Jan; 33(1):34-43. PubMed ID: 28992224
[TBL] [Abstract][Full Text] [Related]
3. High cut-off dialysis in chronic haemodialysis patients.
Girndt M; Fiedler R; Martus P; Pawlak M; Storr M; Bohler T; Glomb MA; Liehr K; Henning C; Templin M; Trojanowicz B; Ulrich C; Werner K; Zickler D; Schindler R
Eur J Clin Invest; 2015 Dec; 45(12):1333-40. PubMed ID: 26519693
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up.
Schepers E; Glorieux G; Eloot S; Hulko M; Boschetti-de-Fierro A; Beck W; Krause B; Van Biesen W
BMC Nephrol; 2018 Jan; 19(1):1. PubMed ID: 29304774
[TBL] [Abstract][Full Text] [Related]
5. Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical Trial.
Zickler D; Schindler R; Willy K; Martus P; Pawlak M; Storr M; Hulko M; Boehler T; Glomb MA; Liehr K; Henning C; Templin M; Trojanowicz B; Ulrich C; Werner K; Fiedler R; Girndt M
PLoS One; 2017; 12(1):e0169024. PubMed ID: 28085888
[TBL] [Abstract][Full Text] [Related]
6. A randomized prospective cross over study on the effects of medium cut-off membranes on T cellular and serologic immune phenotypes in hemodialysis.
Lorenz G; Shen Y; Hausinger RI; Scheid C; Eckermann M; Hornung S; Cardoso J; Lech M; Ribeiro A; Haller B; Holzmann-Littig C; Steubl D; Braunisch MC; Günthner R; Poschenrieder A; Freitag B; Weber M; Luppa P; Heemann U; Schmaderer C
Sci Rep; 2022 Sep; 12(1):16419. PubMed ID: 36180564
[TBL] [Abstract][Full Text] [Related]
7. Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial.
Li PK; Cheng YL; Leung CB; Szeto CC; Chow KM; Kwan BC; Ng ES; Fok QW; Poon YL; Yu AW
Clin J Am Soc Nephrol; 2010 Apr; 5(4):652-8. PubMed ID: 20203165
[TBL] [Abstract][Full Text] [Related]
8. Citrate dialysate does not induce oxidative stress or inflammation in vitro as compared to acetate dialysate.
Pérez-García R; Ramírez Chamond R; de Sequera Ortiz P; Albalate M; Puerta Carretero M; Ortega M; Ruiz Caro MC; Alcazar Arroyo R
Nefrologia; 2017; 37(6):630-637. PubMed ID: 29122211
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled pilot study of 2 weeks' treatment with high cutoff membrane for hemodialysis patients with elevated C-reactive protein.
Fiedler R; Neugebauer F; Ulrich C; Wienke A; Gromann C; Storr M; Böhler T; Seibert E; Girndt M
Artif Organs; 2012 Oct; 36(10):886-93. PubMed ID: 22845695
[TBL] [Abstract][Full Text] [Related]
10. In vitro benchmark of cytokine removal by dialyzers with various permeability profiles.
Hulko M; Speidel R; Gauss J; Storr M; Krause B
Int J Artif Organs; 2017 Oct; 40(11):615-621. PubMed ID: 28862721
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Dialysis of Cytokine-Rich Plasma With High and Medium Cut-Off Membranes Reduces Its Procalcific Activity.
Willy K; Hulko M; Storr M; Speidel R; Gauss J; Schindler R; Zickler D
Artif Organs; 2017 Sep; 41(9):803-809. PubMed ID: 28524237
[TBL] [Abstract][Full Text] [Related]
12. 'Super high-flux' or 'high cut-off' hemofiltration and hemodialysis.
Naka T; Haase M; Bellomo R
Contrib Nephrol; 2010; 166():181-189. PubMed ID: 20473007
[TBL] [Abstract][Full Text] [Related]
13. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
14. Effects of medium cut-off dialysis membranes on inflammation and oxidative stress in patients on maintenance hemodialysis.
Yeter HH; Korucu B; Akcay OF; Derici K; Derici U; Arinsoy T
Int Urol Nephrol; 2020 Sep; 52(9):1779-1789. PubMed ID: 32661626
[TBL] [Abstract][Full Text] [Related]
15. High cut-off dialysis in chronic haemodialysis patients reduces serum procalcific activity.
Zickler D; Willy K; Girndt M; Fiedler R; Martus P; Storr M; Schindler R
Nephrol Dial Transplant; 2016 Oct; 31(10):1706-12. PubMed ID: 27445317
[TBL] [Abstract][Full Text] [Related]
16. Conventional but not high-purity dialysis fluid induces apoptosis and insulin resistance in adipocytes in vitro.
Cai LL; Pan Y; Guo LL; Zhu XJ; Gao FH; Tan LY; Xu QJ; Jin HM
Int J Artif Organs; 2012 May; 35(5):360-8. PubMed ID: 22562372
[TBL] [Abstract][Full Text] [Related]
17. Conventional, but not high-purity, dialysate-induced monocyte apoptosis is mediated by activation of PKC-delta and inflammatory factors release.
Guo LL; Pan Y; Zhu XJ; Tan LY; Xu QJ; Jin HM
Nephrol Dial Transplant; 2011 May; 26(5):1516-22. PubMed ID: 20923925
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory factors for hypoalbuminemia in Japanese peritoneal dialysis patients.
Shioya M; Yoshida T; Kasai K; Furuya R; Kato A; Mori N; Matsumoto Y; Kumagai H
Nephrology (Carlton); 2013 Aug; 18(8):539-44. PubMed ID: 23718260
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
[TBL] [Abstract][Full Text] [Related]
20. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
